M. Shapiro

发表

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.

M. Kris, V. Rusch, C. Azzoli, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer.

C. Reddy, T. Djemil, G. Videtic, 2013, Practical radiation oncology.

The role of adjuvant chemotherapy in early-stage and locally advanced non–small cell lung cancer

M. Shapiro, 2012, Cleveland Clinic Journal of Medicine.

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC

V. Velcheti, G. Videtic, Christopher A. Lemmon, 2022, JTO clinical and research reports.

SELECT: A multicenter phase II trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC.

M. Kris, C. Azzoli, P. Jänne, 2014 .

Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort study

S. Chalikonda, A. Khorana, R. Walsh, 2015, Cancer.

Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An ASCO Quality Training Program Project of the Cleveland Clinic Taussig Cancer Institute.

V. Velcheti, N. Pennell, J. Stevenson, 2016, Journal of oncology practice.

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J. Berlin, A. Maitra, A. Khorana, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

J. Berlin, A. Maitra, A. Khorana, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Data collection for care pathways in the Cleveland Clinic Health System.

B. Bolwell, M. Shapiro, Chad W. Cummings, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I safety and feasibility study of neoadjuvant chemoradiation plus pembrolizumab followed by consolidation pembrolizumab in resectable stage IIIA non-small cell lung cancer.

V. Velcheti, S. Murthy, G. Videtic, 2020 .

An Open‐Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non‐Small Cell Lung Cancer

N. Pennell, P. Patil, N. Hashemi Sadraei, 2019, The oncologist.